NZ192873A - Cephalosporin derivatives:preparation and pharmaceutical compositions - Google Patents
Cephalosporin derivatives:preparation and pharmaceutical compositionsInfo
- Publication number
- NZ192873A NZ192873A NZ192873A NZ19287380A NZ192873A NZ 192873 A NZ192873 A NZ 192873A NZ 192873 A NZ192873 A NZ 192873A NZ 19287380 A NZ19287380 A NZ 19287380A NZ 192873 A NZ192873 A NZ 192873A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compound
- acid
- syn
- substituted
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH154579A CH641810A5 (en) | 1979-02-16 | 1979-02-16 | Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them |
| CH17480A CH645378A5 (en) | 1980-01-10 | 1980-01-10 | Acetamidocephalosporanic acid derivatives, process for their preparation and pharmaceutical forms which contain them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ192873A true NZ192873A (en) | 1984-07-31 |
Family
ID=25683752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ192873A NZ192873A (en) | 1979-02-16 | 1980-02-14 | Cephalosporin derivatives:preparation and pharmaceutical compositions |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4477448A (OSRAM) |
| AT (1) | AT374806B (OSRAM) |
| CA (1) | CA1161032A (OSRAM) |
| DE (1) | DE3005012A1 (OSRAM) |
| DK (1) | DK53780A (OSRAM) |
| ES (2) | ES8102134A1 (OSRAM) |
| FI (1) | FI800381A7 (OSRAM) |
| FR (1) | FR2449093A1 (OSRAM) |
| GB (2) | GB2046734B (OSRAM) |
| IE (1) | IE49395B1 (OSRAM) |
| IL (1) | IL59391A (OSRAM) |
| IT (1) | IT8047922A0 (OSRAM) |
| MY (1) | MY8500128A (OSRAM) |
| NL (1) | NL8000894A (OSRAM) |
| NZ (1) | NZ192873A (OSRAM) |
| PH (1) | PH17926A (OSRAM) |
| PT (1) | PT70834A (OSRAM) |
| SE (2) | SE8000982L (OSRAM) |
| YU (1) | YU40280A (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0037380B1 (en) * | 1980-03-28 | 1984-09-12 | BIOCHEMIE Gesellschaft m.b.H. | New process for the production of cephalosporin antibiotics, and novel intermediates used in such process and their production |
| CH648038A5 (de) * | 1981-01-19 | 1985-02-28 | Sandoz Ag | 7-((carboxymethoxyimino)-1h-pyrazol-3-yl-acetyl)amino-3-desacetoxy-3-(1-methyl-1h-tetrazol-5-yl-thio)cephalosporansaeure und salze, verfahren zur herstellung und verwendung. |
| GB2125033B (en) * | 1982-07-23 | 1985-08-29 | Servipharm Ltd | Cephalosporins |
| US4698338A (en) * | 1986-02-19 | 1987-10-06 | Eli Lilly And Company | 7[2-(2-aminothiazol-4-yl)-2-benzyloximino]acetamido-3[4-alkyl-5-oxo-6-hydroxy-3,4-dihydro-1,2,4-triazin-3-yl]thiomethyl cephalosporins |
| US5688964A (en) * | 1996-02-13 | 1997-11-18 | Eastman Kodak Company | Process for preparing a acylhyrazino pyrazole derivative |
| EP1219173B1 (en) * | 1999-09-24 | 2004-06-16 | Agro-Kanesho Co., Ltd. | Insecticides and acaricides |
| JP4202250B2 (ja) | 2001-07-25 | 2008-12-24 | バイオマリン ファーマシューティカル インコーポレイテッド | 血液脳関門輸送を調節するための組成物および方法 |
| CA2608144C (en) | 2005-04-28 | 2012-11-13 | Proteus Biomedical, Inc. | Pharma-informatics system |
| EP2063905B1 (en) | 2006-09-18 | 2014-07-30 | Raptor Pharmaceutical Inc | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
| ES2919563T3 (es) | 2009-02-20 | 2022-07-27 | Enhanx Biopharm Inc | Sistema de administración de medicamentos a base de glutatión |
| KR101741629B1 (ko) | 2009-05-06 | 2017-05-31 | 라보라토리 스킨 케어, 인크. | 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법 |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4024137A (en) * | 1971-05-14 | 1977-05-17 | Glaxo Laboratories Limited | 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins |
-
1980
- 1980-02-07 FI FI800381A patent/FI800381A7/fi not_active Application Discontinuation
- 1980-02-07 SE SE8000982A patent/SE8000982L/xx not_active Application Discontinuation
- 1980-02-07 DK DK53780A patent/DK53780A/da not_active Application Discontinuation
- 1980-02-11 DE DE19803005012 patent/DE3005012A1/de not_active Withdrawn
- 1980-02-12 GB GB8004696A patent/GB2046734B/en not_active Expired
- 1980-02-13 NL NL8000894A patent/NL8000894A/nl not_active Application Discontinuation
- 1980-02-13 FR FR8003143A patent/FR2449093A1/fr active Granted
- 1980-02-14 PT PT70834A patent/PT70834A/pt unknown
- 1980-02-14 CA CA000345659A patent/CA1161032A/en not_active Expired
- 1980-02-14 NZ NZ192873A patent/NZ192873A/en unknown
- 1980-02-14 AT AT0078780A patent/AT374806B/de not_active IP Right Cessation
- 1980-02-14 YU YU00402/80A patent/YU40280A/xx unknown
- 1980-02-14 IE IE284/80A patent/IE49395B1/en unknown
- 1980-02-14 IL IL59391A patent/IL59391A/xx unknown
- 1980-02-15 ES ES488651A patent/ES8102134A1/es not_active Expired
- 1980-02-15 IT IT8047922A patent/IT8047922A0/it unknown
- 1980-02-15 PH PH23650A patent/PH17926A/en unknown
- 1980-11-20 ES ES497002A patent/ES8203848A1/es not_active Expired
-
1982
- 1982-06-21 US US06/390,323 patent/US4477448A/en not_active Expired - Fee Related
-
1983
- 1983-04-11 GB GB08309730A patent/GB2117774B/en not_active Expired
-
1985
- 1985-02-08 SE SE8500589A patent/SE8500589D0/xx unknown
- 1985-12-30 MY MY128/85A patent/MY8500128A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2449093B1 (OSRAM) | 1983-07-29 |
| MY8500128A (en) | 1985-12-31 |
| ES497002A0 (es) | 1982-04-01 |
| SE8500589D0 (sv) | 1985-02-08 |
| FI800381A7 (fi) | 1981-01-01 |
| PT70834A (en) | 1980-03-01 |
| IL59391A (en) | 1983-05-15 |
| IE49395B1 (en) | 1985-10-02 |
| AT374806B (de) | 1984-06-12 |
| PH17926A (en) | 1985-01-31 |
| ES488651A0 (es) | 1980-12-16 |
| DE3005012A1 (de) | 1980-11-27 |
| GB2117774B (en) | 1984-03-21 |
| IT8047922A0 (it) | 1980-02-15 |
| SE8000982L (sv) | 1980-08-17 |
| ES8203848A1 (es) | 1982-04-01 |
| YU40280A (en) | 1983-06-30 |
| CA1161032A (en) | 1984-01-24 |
| US4477448A (en) | 1984-10-16 |
| GB2117774A (en) | 1983-10-19 |
| FR2449093A1 (fr) | 1980-09-12 |
| IL59391A0 (en) | 1980-05-30 |
| GB2046734B (en) | 1983-09-01 |
| GB2046734A (en) | 1980-11-19 |
| ES8102134A1 (es) | 1980-12-16 |
| ATA78780A (de) | 1983-10-15 |
| NL8000894A (nl) | 1980-08-19 |
| IE800284L (en) | 1980-08-16 |
| DK53780A (da) | 1980-08-17 |
| GB8309730D0 (en) | 1983-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4080498A (en) | 7-Alpha-(2-aminothiazole)-acetamido-cephalosporins | |
| US9085589B2 (en) | Cephem derivative | |
| WO2009074810A1 (en) | Antibacterial compositions | |
| NZ192873A (en) | Cephalosporin derivatives:preparation and pharmaceutical compositions | |
| EP0034760A1 (de) | Cephalosporinderivate, sie enthaltende pharmazeutische Präparate und Verfahren zu ihrer Herstellung | |
| NO152751B (no) | Analogifremgangsmaate ved fremstilling av et terapeutisk virksomt cephalosporinderivat | |
| NO791246L (no) | Beta-lactamantiniotika. | |
| CS199714B2 (en) | Process for preparing heteromonocyclic and heterobicyclic derivatives of unsaturated 7-acylamido-3-cephem-4-carboxylic acids | |
| HU188586B (en) | Process for producing new cepheme derivatives | |
| US3907786A (en) | 7-{8 {60 -(2-aminomethyl-1,4-cyclohexadienyl)acetamido{9 -3-heterocyclic-thiomethyl-3-cephem-4-carboxylic acids and salts | |
| NO160080B (no) | Analogifremgangsmaate for fremstilling av en ny terapeutisk aktiv syn-isomer av en 3-vinyl-3-cefem-forbindelse og farmasoeytisk godtagbare salter og estere derav. | |
| US3459746A (en) | 7 - heteromonocyclic-substituted acylamido derivatives of desacetyl cephalosporanic acid | |
| NO750351L (OSRAM) | ||
| NL8103751A (nl) | 7-beta-(alfa-syn-methoxyimino-alfa-(2-aminothiazol-4yl)aceetamido)-3-((1,2,3-thiazol-5-ylthio)methyl)-3cefem-4-carbonzuur en alkylderivaten daarvan. | |
| US4609654A (en) | Derivatives of cephalosporins substituted in 3 position by a thiomethyl heterocycle group; and pharmaceutical compositions containing them | |
| NO752202L (OSRAM) | ||
| US3217000A (en) | 7-thienylmercaptoacetamido-cephalo-sporanic acid derivatives | |
| US4311842A (en) | Cephalosporin compounds | |
| HK5395A (en) | Intermediary products of cephalosporine, preparation process thereof and utilization thereof | |
| US4503221A (en) | Process for cephalosporanic acid derivatives and intermediate therefor | |
| US5484928A (en) | 2-(2-aminothiazol-4-yl)-2-oxoacetic acid derivatives | |
| US4107440A (en) | Intermediates for preparing substituted phenylglycylcephalosporins | |
| US4058609A (en) | 7-Dithioacetamido cephalosporins | |
| SE454512B (sv) | 7beta-isotiazolyltioacetamido-7alfa-metoxicefalosporansyraderivat | |
| US3823141A (en) | 7-(o-aminomethyl-p-hydroxy-phenylacetamido)-3-(3-hydroxy-pyridazin-6-ylthiomethyl)-3-cephem-4-carboxylic acid |